John D Altman MD
Adult Congenital Heart Disease, Interventional Cardiology
Physician
Join to view full profile
2827 FORT MISSOULA RDMissoula, MT 59804
Dr. Altman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 1999 - 2001
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1996 - 1999- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1992 - 1995
University of Minnesota Medical SchoolClass of 1992
Certifications & Licensure
CA State Medical License 1993 - Present
MT State Medical License 2022 - 2028
NE State Medical License 2020 - 2028
CO State Medical License 2018 - 2027
KS State Medical License 2018 - 2027
MO State Medical License 2022 - 2027
ND State Medical License 2019 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2014, 2017
- CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2014
Clinical Trials
- Physiologic Assessment of Coronary Stenosis Following PCI Start of enrollment: 2017 Jun 20
- Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR) Start of enrollment: 2019 Aug 01
- A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) Start of enrollment: 2021 May 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Peptide exchange-competent class I MHC molecules produced in eukaryotic cells for rapid production of MHC multimers.Vasanthi Ramachandiran, John C Shires, Richard A Willis, Ge Bai, Donielle L Bell
Journal of Immunology. 2026-08-04 - 15 citationsIntravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions: The ECLIPSE Trial.Gregg W Stone, Philippe Genereux, Akiko Maehara, Bruce E Lewis, Richard A Shlofmitz
JACC. Cardiovascular Interventions. 2025-10-13 - 138 citationsPaclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.Robert W Yeh, Richard Shlofmitz, Jeffrey Moses, William Bachinsky, Suhail Dohad
JAMA. 2024-03-26
Grant Support
- Tetramer Facility For Immune-Mediated Diseases ResearchNational Institute Of Allergy And Infectious Diseases2011
- Tetramer Facility For Biodefense ResearchNational Institute Of Allergy And Infectious Diseases2011
- Tetramer Facility For AIDS ResearchNational Institute Of Allergy And Infectious Diseases2011
- Mechanisms Of Help For CD8 T Cell ResponsesNational Center For Research Resources2011
- Influenza Pathogenesis And Immunology Research Center:T Cell ResponsesNational Center For Research Resources2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
